22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
BUFFALO, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, to…
- Second Quarter 2023 Net Revenues Increased 62% to $23.4 Million
- Launched VLN® Sales in California, Texas and Florida
- Delivered Record GVB Ingredient Volumes as Dominant Suppli…